Kenta Hayashino

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy.

The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy.

Journal: Transplantation and cellular therapy

Published: April 14, 2026

Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis.

Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis.

Journal: Acta medica Okayama

Published: December 24, 2025

Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.

Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 30, 2025

Successful Neutrophil Engraftment with Continued Ruxolitinib in Cord Blood Transplantation.

Successful Neutrophil Engraftment with Continued Ruxolitinib in Cord Blood Transplantation.

Journal: Blood cell therapy

Published: May 28, 2025

Cardiovascular toxicity from tyrosine kinase inhibitors in chronic myeloid leukemia with severe dilated cardiomyopathy.

Cardiovascular toxicity from tyrosine kinase inhibitors in chronic myeloid leukemia with severe dilated cardiomyopathy.

Journal: International journal of hematology

Published: April 17, 2025

Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.

Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.

Journal: International journal of hematology

Published: February 19, 2025

A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature review.

A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature review.

Journal: International journal of hematology

Published: February 10, 2025

Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndrome.

Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndrome.

Journal: Cytotherapy

Published: November 29, 2024

A fatal case of enterovirus A71-induced meningoencephalitis following allogenic hematopoietic stem cell transplantation.

A fatal case of enterovirus A71-induced meningoencephalitis following allogenic hematopoietic stem cell transplantation.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: October 07, 2024

Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors.

Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors.

Journal: International journal of hematology

Published: October 01, 2024

Myelodysplastic neoplasms with repeating TAFRO syndrome-like symptoms.

Myelodysplastic neoplasms with repeating TAFRO syndrome-like symptoms.

Journal: International journal of hematology

Published: September 23, 2024

Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.

Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 27, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026